Maharashtra deputy chief minister Eknath Shinde has directed the state health department to include rare diseases under the Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY), according to a statement. The move is aimed at ensuring timely diagnosis and effective treatment for patients with rare diseases such as Spinal Muscular Atrophy (SMA), while shielding their families from the financial burden of expensive medical care.

Shinde also asked the department to prepare a comprehensive standard operating procedure for treating SMA patients and to strengthen early diagnosis, patient registration and treatment processes. The directions came during a meeting on Wednesday where officials discussed the current status of SMA patients in Maharashtra, diagnosis, available treatment options, medicine availability and the challenges patients face.

The central government has selected KEM Hospital in Mumbai as the Centre of Excellence for Maharashtra, undertaking diagnosis of rare diseases, patient registration and related treatment procedures. Noting that a clearly defined protocol is needed for patients to receive treatment easily and in time, Shinde directed the health department to prepare a proposal and send it to the Union health ministry for Centre of Excellence status for Wadia Children's Hospital in Mumbai, where SMA treatment facilities are also available. He said he will personally write to the Union health minister and follow up on the matter.

Shinde further directed the department to begin the process of including the disease under MJPJAY so that treatment is not delayed due to financial constraints. He also said KEM Hospital should add the essential medicines required for treating the disease to its essential medicines list and procure them accordingly.